RNAGene Inc.
PrivateLast Round
Series A
Extension
Oct 8, 2024
Total Funding Raised
$1.47M
Company Overview
RNAGene Inc. is a biotechnology company that develops mRNA-based therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNAGene Inc. Comparables
Compare RNAGene Inc. with similar companies based on industry and business-model similarity.
RNAGene Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 8, 2024 |
RNAGene Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angel Lounge | Series A Extension |
| AI Angel Club | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2024
$1.47M round from AI Angel Club and Angel Lounge.
RNAGene Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RNAGene Inc.'s valuation, stock price, and market status.